A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248

This treatment has been approved for sale to the public.

Sponsor:

Information provided by (Responsible Party):

Pfizer

ClinicalTrials.gov Identifier:

NCT00094029

First received: October 8, 2004

Last updated: March 8, 2012

Last verified: March 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This treatment has been approved for sale to the public.
Study Completion Date:	October 2011
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)

No publications provided by Pfizer

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):